Androgen deprivation-induced senescence

Androgen deprivation-induced senescence
Androgen deprivation-induced senescence
Specialty	Endocrinology

Androgen deprivation-induced senescence (or ADIS) refers to the induction of cellular senescence as a result of androgen deprivation therapy.^[1]^[2]^[3]^[4]^[5] ADIS is observed in prostate cancer cells that are dependent on androgens for cell proliferation. Androgen withdrawal induces cells to undergo cellular senescence by up-regulating intracellular reactive oxygen species (ROS) that cause DNA damage. ADIS is maintained through the up-regulation of the cell cycle regulator p16ink4a.

References

^ Pernicová, Z; Slabáková, E; Kharaishvili, G; Bouchal, J; Král, M; Kunická, Z; Machala, M; Kozubík, A; Souček, K (June 2011). "Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2". Neoplasia. 13 (6): 526–36. doi:10.1593/neo.11182. PMC 3114246. PMID 21677876.
^ Ewald, JA; Desotelle, JA; Church, DR; Yang, B; Huang, W; Laurila, TA; Jarrard, DF (March 2013). "Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo". The Prostate. 73 (4): 337–45. doi:10.1002/pros.22571. PMC 4753826. PMID 22911222.
^ Burton, Dominick G. A.; Giribaldi, Maria G.; Munoz, Anisleidys; Halvorsen, Katherine; Patel, Asmita; Jorda, Merce; Perez-Stable, Carlos; Rai, Priyamvada; Agoulnik, Irina U. (27 June 2013). Agoulnik, Irina U (ed.). "Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells". PLOS ONE. 8 (6): e68003. Bibcode:2013PLoSO...868003B. doi:10.1371/journal.pone.0068003. PMC 3695935. PMID 23840802.
^ Barakat et al (2015). CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells Oncogene {{doi:10.1038/onc.2015.41}}
^ Kawata, Hirotoshi; Kamiakito, Tomoko; Nakaya, Takeo; Komatsubara, Maiko; Komatsu, Kenji; Morita, Tatsuo; Nagao, Yasumitsu; Tanaka, Akira (2017). "Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer". The Journal of Steroid Biochemistry and Molecular Biology. 165 (Pt B): 219–227. doi:10.1016/j.jsbmb.2016.06.007. PMID 27329245. S2CID 6273648.

This article about an endocrine, nutritional, or metabolic disease is a stub. You can help Wikipedia by expanding it.

[1] Pernicová, Z; Slabáková, E; Kharaishvili, G; Bouchal, J; Král, M; Kunická, Z; Machala, M; Kozubík, A; Souček, K (June 2011). "Androgen depletion induces senescence in prostate cancer cells through down-regulation of Skp2". Neoplasia. 13 (6): 526–36. doi:10.1593/neo.11182. PMC 3114246. PMID 21677876.

[2] Ewald, JA; Desotelle, JA; Church, DR; Yang, B; Huang, W; Laurila, TA; Jarrard, DF (March 2013). "Androgen deprivation induces senescence characteristics in prostate cancer cells in vitro and in vivo". The Prostate. 73 (4): 337–45. doi:10.1002/pros.22571. PMC 4753826. PMID 22911222.

[3] Burton, Dominick G. A.; Giribaldi, Maria G.; Munoz, Anisleidys; Halvorsen, Katherine; Patel, Asmita; Jorda, Merce; Perez-Stable, Carlos; Rai, Priyamvada; Agoulnik, Irina U. (27 June 2013). Agoulnik, Irina U (ed.). "Androgen Deprivation-Induced Senescence Promotes Outgrowth of Androgen-Refractory Prostate Cancer Cells". PLOS ONE. 8 (6): e68003. Bibcode:2013PLoSO...868003B. doi:10.1371/journal.pone.0068003. PMC 3695935. PMID 23840802.

[4] Barakat et al (2015). CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells Oncogene {{doi:10.1038/onc.2015.41}}

[5] Kawata, Hirotoshi; Kamiakito, Tomoko; Nakaya, Takeo; Komatsubara, Maiko; Komatsu, Kenji; Morita, Tatsuo; Nagao, Yasumitsu; Tanaka, Akira (2017). "Stimulation of cellular senescent processes, including secretory phenotypes and anti-oxidant responses, after androgen deprivation therapy in human prostate cancer". The Journal of Steroid Biochemistry and Molecular Biology. 165 (Pt B): 219–227. doi:10.1016/j.jsbmb.2016.06.007. PMID 27329245. S2CID 6273648.

[1]

[2]

[3]

[4]

[5]